Amolyt Pharma logo

Amolyt Pharma jobs and careers

Écully, France

About Amolyt Pharma

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.

Founded in 2015 by Thierry Abribat.

Founded
2015
Employees
11 to 50
Total funding
$311.3M
Headquarters
Écully

Leadership

The top of Amolyt Pharma's org chart, with how many people report into each leader.

CF

Caroline Robo (Fesquet)

Director Regulatory Affairs

3 reports

GD

Guillaume Ravel, PharmD, PhD, DABT

Director, Preclinical Development

1 report

HBPhoto of Héloïse Boullet

Héloïse Boullet

Innovation Manager

LO

Laetitia Ouafki

Director of Quality Assurance

PLPhoto of Patrick Loustau

Patrick Loustau

Chief Business Officer

MCPhoto of Michael Culler

Michael Culler

Chief Scientific Officer

MOPhoto of michel ovize

michel ovize

Senior Medical Director

JNPhoto of Jeanine Nguy

Jeanine Nguy

Regulatory Affairs Senior Manager

EMPhoto of Eva MARCON

Eva MARCON

Senior Manager Drug Device Combination

DGPhoto of Divya Gupta

Divya Gupta

Senior Manager, Global Regulatory Lead

ALPhoto of Arnaud LAVEISSIERE

Arnaud LAVEISSIERE

Ass. Dir. Preclinical Development